CD95 Extracellular Domain (human, recombinant) Reference: 32036-50 Source: Recombinant C-terminal human IgG1 Fc-tagged CD95 extracellular domain expressed in HEK293 cells • Amino acids: 26-173 • MW: 43.4 kDa
PDE2A (human, recombinant, aa 215-900) Reference: 32037-20 Source: Recombinant human C-terminal His-tagged PDE2A expressed in insect cells • Amino acids: 215-900 • MW: 80 kDa
PION blocking peptide Reference: GTX32001-PEP Accumulation of neurotoxic amyloid-beta is a major hallmark of Alzheimer disease (AD; MIM 143). Formation of amyloid-beta is catalyzed by gamma-secretase (see PSEN1; MIM 14311), a protease with numerous substrates. PION, or GSAP, selectively increases amyloid-beta production through a mechanism involving its interaction with both gamma-secretase and its substrate, the amyloid-beta precursor protein (APP; MIM 1476) C-terminal fragment (APP-CTF) (He et al., 21 [PubMed 2811458]).[supplied by OMIM, Nov 21]
PDE2A (human, recombinant, aa 215-900) Reference: 32037-50 Source: Recombinant human C-terminal His-tagged PDE2A expressed in insect cells • Amino acids: 215-900 • MW: 80 kDa
PDE4B2 (human, recombinant) Reference: 32038-20 Recombinant human N-terminal His-GST-tagged PDE4B2 expressed in insect cells • Amino acids: 1-564 • MW: 92.2 kDa
PDE4B2 (human, recombinant) Reference: 32038-50 Recombinant human N-terminal His-GST-tagged PDE4B2 expressed in insect cells • Amino acids: 1-564 • MW: 92.2 kDa
PDE9A2 (human, recombinant) Reference: 32039-100 Source: Recombinant human N-terminal His-GST-tagged PDE9A2 expressed in insect cells • Amino acids: 1-533 (full length) • MW: 89.5 kDa